Furthermore, we found that MSC derived from the bone marrow of MM patients have a much lower proliferative capacity than cells from healthy individuals and overproduce Dickkopf-related protein 1 (DKK1), a Wnt-pathway antagonist [8,9,10]. This evidence concerns the gene DKK1 and Miyoshi myopathy.